Keynote: The Next Frontier of Cell Therapy: Clinical Progress in In Vivo Car-T for Multiple Myeloma

Thu, Mar 18 | 09:00 AM - 09:20 AM

General Session

Speaker:

John Pagel, MD, PhD SVP, Clinical Development, Global Head Medical Oncology, Hematology Eli Lilly and Co

Industry Specific Content:

Science & Clinical Development , Cell Therapy

Track:

General Session